✦ LIBER ✦

738 A one year randomized, placebo-controlled, double-blind trial of rosiglitazone in non-alcoholic steatohepatitis: Results of the flirt pilot trial

✍ Scribed by V. Ratziu; F. Charlotte; S. Jacqueminet; P. Giral; P. Podevin; L. Serfaty; E. Bruckert; T. Poynard

Book ID: 117375013
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 126 KB
Volume: 44
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(06)80738-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[755] UTILITY OF A COMBINATION OF NON-IN

[755] UTILITY OF A COMBINATION OF NON-INVASIVE BIOMARKERS (FIBROMAX) IN ASSESSING THE EFFICACY OF ROSIGLITAZONE IN A ONE YEAR RANDOMIZED, DOUBLE-BLIND TRIAL IN NON ALCOHOLIC STEATOHEPATITIS

✍ M. Munteanu; T. Poynard; F. Charlotte; S. Jacqueminot; D. Messous; P. Podevin; L 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 136 KB

α1-Antitrypsin in Fibromyalgia: Results

α1-Antitrypsin in Fibromyalgia: Results of a Randomized, Placebo-Controlled, Double-Blind and Crossover Pilot Trial

✍ Cayetano Alegre; Mireia Barceló; Rosendo Jardí; Francisco Rodríguez-Frias; Sandr 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 609 KB

Metadoxine accelerates fatty liver recov

Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial

✍ Joan Caballería; Albert Parés; Concepció Brú; José Mercader; Antonio Garcia Plaz 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Effect of Pentoxifylline on GFR Decline

Effect of Pentoxifylline on GFR Decline in CKD: A Pilot, Double-Blind, Randomized, Placebo-Controlled Trial

✍ Robert M. Perkins; Matthew C. Aboudara; Alice L. Uy; Stephen W. Olson; Howard M. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 690 KB

Selenium Supplementation and the Inciden

Selenium Supplementation and the Incidence of Preeclampsia in Pregnant Iranian Women: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial

✍ Fatemeh Tara; Gholamali Maamouri; Margaret P. Rayman; Majid Ghayour-Mobarhan; Am 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Interferon-α does not improve outcome at

Interferon-α does not improve outcome at one year in patients with diffuse cutaneous scleroderma: Results of a randomized, double-blind, placebo-controlled trial

✍ Carol M. Black; Alan J. Silman; Ariane I. Herrick; Christopher P. Denton; Helen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 1 views

## Objective: To determine whether interferon-alpha (ifnalpha) reduces the severity of skin involvement in early (<3 years) diffuse scleroderma. ## Methods: In a randomized, placebo-controlled, double-blind trial, 35 patients with early scleroderma received subcutaneous injections of either ifnal